Egnyte (Mountain View, CA) has announced a new document stamping service to certify and authenticate documents, files, reports, and content stored within the Egnyte repository.
The service allows for a permanent, time-stamped record to be created on the public blockchain with cryptographic proofs for documents, creating a digital record of authorship and allowing any authorized party to inspect and validate the document as it is certified without implicitly trusting vendor statements.
Greg Neustetter, Egnyte‘s vice president of product, commented: “We are seeing customers who need to validate their documents for drug trials and companies working on large infrastructure projects that need to make traceable processes. Adding document stamping to the Egnyte platform enables companies of any size to solve these problems without understanding the complexities of blockchain.”
Egnyte is currently launching a pilot program for life science customers to stamp audit reports, providing authenticity and integrity within their GxP-compliant domains.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.